1,898 articles

Advances in bevacizumab in colorectal cancer: a bibliometric analysis from 2004 to 2023

in Cancer Molecular Targets and Therapeutics

• Hao Chen
• Yeqing Lei
• Junjie Zhou
• Chenhui Lv
• Qijia Xuan

A seven-LncRNA signature for prognosis prediction of patients with lung squamous cell carcinoma through tumor immune escape

in Cancer Molecular Targets and Therapeutics

• Qiangqiang Ge
• Zhong Lin
• Xuequan Wang
• Zhengli Jiang
• Yan Hu

Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma

in Cancer Molecular Targets and Therapeutics

• Ângela Marques-Magalhães
• Filipa Moreira-Silva
• Inês Graça
• Paula C. Dias
• Margareta P. Correia
• Maria Ana Alzamora
• Rui Henrique
• Marie Lopez
• Paola B. Arimondo
• Vera Miranda-Gonçalves

Durable response to Olaparib in EGFR and somatic BRCA2-mutated lung adenocarcinoma with leptomeningeal metastases: a case report

in Cancer Molecular Targets and Therapeutics

• Fang-fang Hou
• Li-rong Liu
• Wen-jie Zhao
• Yan-chun Qu
• Rui Zhou
• Tian-lin Wang
• Yong-song Ye
• Xiao-shu Chai
• Hai-bo Zhang

Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance

in Cancer Molecular Targets and Therapeutics

• Andrew J. Kavran
• Yulong Bai
• Brian Rabe
• Anna Kreshock
• Andrew Fisher
• Yelena Cheng
• Anne Lewin
• Chao Dai
• Matthew J. Meyer
• Konstantinos J. Mavrakis

Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management

in Cancer Molecular Targets and Therapeutics

• Fidelis Charles Bugoye
• Rispah Torrorey-Sawe
• Richard Biegon
• Nazima Dharsee
• Fidelice Mafumiko
• Herry Kibona
• Said Aboud
• Kirtika Patel
• Simeon Mining

A novel lactylation-related gene signature to predict prognosis and treatment response in lung adenocarcinoma

in Cancer Molecular Targets and Therapeutics

• Hongyi Zhang
• Yihao Liu
• Xuanguang Li
• Chen Ding
• Chunqiu Xia
• Hua Huang
• Hongyu Liu
• Jun Chen

Mapping MAGE-A4 expression in solid cancers for targeted therapies

in Cancer Molecular Targets and Therapeutics

• Christin Habigt
• Sylvie Rottey
• Iben Spanggaard
• Juanita S. Lopez
• Elena Garralda
• Emiliano Calvo
• Oliver Bechter
• Jayesh Desai
• Rachel Galot
• Leena Gandhi

Immuno-inflammatory mechanisms in cardio-oncology: new hopes for immunotargeted therapies

in Cancer Molecular Targets and Therapeutics

• Meiqi Miao
• Xinxin Liu
• Han Zhang
• Hailong Dai

Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR

in Cancer Molecular Targets and Therapeutics

• Jinhao Chen
• Qianru Wang
• Hongyan Wu
• Xiaofei Huang
• Chunyu Cao

Prognostic value of CA125 in diffuse large B-cell lymphoma

in Cancer Molecular Targets and Therapeutics

• Jie Zhang
• Yijing Jiang
• Long Chen
• Linyan Xu
• Bojian Ge
• Xiaobing Miao
• Xiaohong Xu

Editorial: Molecular mechanisms and therapeutic targets of cancer metastasis and therapy resistance

in Cancer Molecular Targets and Therapeutics

• Ya-Wen Wang
• Xu Chen

Retraction: Corrigendum: Upregulation of CCT-3 induces breast cancer cell proliferation through miR-223 competition and Wnt/b-catenin signaling pathway activation

in Cancer Molecular Targets and Therapeutics

Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas

in Cancer Molecular Targets and Therapeutics

• Bowen Wang
• Mengjia Peng
• Yan Li
• Jinhang Gao
• Tao Chang

From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates

in Cancer Molecular Targets and Therapeutics

• Heidi C. Ko
• Kyle C. Strickland
• Dana Jaggessarsingh
• Alicia Dillard
• Michelle Green
• Erin Newburn
• Tiffany Sellaro
• Jonathan L. Klein
• Brian Caveney
• Marcia Eisenberg

Adoptive cell therapy against tumor immune evasion: mechanisms, innovations, and future directions

in Cancer Molecular Targets and Therapeutics

• Liqin Ruan
• Lu Wang